These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1415679)

  • 1. Functional changes in salivary glands of autoimmune disease-prone NOD mice.
    Hu Y; Nakagawa Y; Purushotham KR; Humphreys-Beher MG
    Am J Physiol; 1992 Oct; 263(4 Pt 1):E607-14. PubMed ID: 1415679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice.
    Robinson CP; Yamamoto H; Peck AB; Humphreys-Beher MG
    Clin Immunol Immunopathol; 1996 Apr; 79(1):50-9. PubMed ID: 8612351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.
    Robinson CP; Yamachika S; Alford CE; Cooper C; Pichardo EL; Shah N; Peck AB; Humphreys-Beher MG
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5767-71. PubMed ID: 9159148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation.
    Yamamoto H; Sims NE; Macauley SP; Nguyen KH; Nakagawa Y; Humphreys-Beher MG
    Clin Immunol Immunopathol; 1996 Mar; 78(3):245-55. PubMed ID: 8605700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of alterations in the levels of neuropeptides and salivary gland responses in the non-obese diabetic mouse model for autoimmune sialoadenitis.
    Yamamoto H; Ishibashi K; Nakagawa Y; Maeda N; Zeng T; Robinson CP; Oxford GE; Chegini N; Humphreys-Beher MG
    Scand J Immunol; 1997 Jan; 45(1):55-61. PubMed ID: 9010501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production.
    Matsui-Inohara H; Uematsu H; Narita T; Satoh K; Yonezawa H; Kuroda K; Ito T; Yoneda S; Kawarai T; Sugiya H; Watanabe H; Senpuku H
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1525-36. PubMed ID: 19934373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland cytokine expression in NOD and normal BALB/c mice.
    Yamano S; Atkinson JC; Baum BJ; Fox PC
    Clin Immunol; 1999 Sep; 92(3):265-75. PubMed ID: 10479531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant proteolytic digestion of biglycan and decorin by saliva and exocrine gland lysates from the NOD mouse model for autoimmune exocrinopathy.
    Yamachika S; Brayer J; Oxford GE; Peck AB; Humphreys-Beher MG
    Clin Exp Rheumatol; 2000; 18(2):233-40. PubMed ID: 10812497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.
    Nanni JM; Nguyen KH; Alford CE; Robinson CP; Stewart CM; Maeda N; Humphreys-Beher MG
    Clin Exp Rheumatol; 1997; 15(5):515-21. PubMed ID: 9307859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?
    Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP
    Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of insulin and insulin-like growth factors I and II in saliva and potential synthesis in the salivary glands of mice. Effects of type 1 diabetes mellitus.
    Kerr M; Lee A; Wang PL; Purushotham KR; Chegini N; Yamamoto H; Humphreys-Beher MG
    Biochem Pharmacol; 1995 May; 49(10):1521-31. PubMed ID: 7763295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy.
    Soyfoo MS; De Vriese C; Debaix H; Martin-Martinez MD; Mathieu C; Devuyst O; Steinfeld SD; Delporte C
    Arthritis Rheum; 2007 Aug; 56(8):2566-74. PubMed ID: 17665453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitinase expression in parotid glands of non-obese diabetic mice.
    Fukushima T; Nashida T; Haga-Tsujimura M; Mataga I
    Oral Dis; 2012 Jul; 18(5):506-12. PubMed ID: 22309644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome.
    Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG
    J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereology and ultrastructure of the salivary glands of diabetic Nod mice submitted to long-term insulin treatment.
    Caldeira EJ; Camilli JA; Cagnon VH
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Oct; 286(2):930-7. PubMed ID: 16142810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSP expression in murine lacrimal glands and function as a bacteria binding protein in exocrine secretions.
    Robinson CP; Bounous DI; Alford CE; Nguyen KH; Nanni JM; Peck AB; Humphreys-Beher MG
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G863-71. PubMed ID: 9142919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome.
    Humphreys-Beher MG; Hu Y; Nakagawa Y; Wang PL; Purushotham KR
    Adv Exp Med Biol; 1994; 350():631-6. PubMed ID: 8030546
    [No Abstract]   [Full Text] [Related]  

  • 18. Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis.
    Rosignoli F; Roca V; Meiss R; Leceta J; Gomariz RP; Pérez Leirós C
    Clin Exp Immunol; 2005 Dec; 142(3):411-8. PubMed ID: 16297151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced oral wound healing in the NOD mouse model for type 1 autoimmune diabetes and its reversal by epidermal growth factor supplementation.
    Nagy A; Nagashima H; Cha S; Oxford GE; Zelles T; Peck AB; Humphreys-Beher MG
    Diabetes; 2001 Sep; 50(9):2100-4. PubMed ID: 11522677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialoadenitis progression in nonobese diabetic mice and its correlation with expression of apoptosis-associated proteins in salivary glands and serum IgG levels.
    Qi G; Hua H; Gao Y; Lin Q; Yu GY
    Chin Med J (Engl); 2007 Aug; 120(16):1426-31. PubMed ID: 17825172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.